![]() |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
Guide to AuthorsWelcome to the electronic manuscript submission website for Leukemia. The instructions below are structured so you can quickly and easily answer the following questions:
OTHER LINKSABOUT THE JOURNALScopeLeukemia covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Leukemia aims at publishing good, solid, innovative science applied to 80% translational research and 20% pure science. All data that may lead to targeted therapy in a biologically relevant and leukemia specific fashion are eagerly sought after.Topics Covered Topics of interest are studies on oncogenes, growth factors, stem cells, gene transfer chromosomes, cell cycle, receptors, cell and membrane markers, and more.
Editorial NoteThe types of communication published in Leukemia reflect the mission of the journal to promote an effective transfer of results and ideas in a cross-fertilizing traffic from bench to clinic and the reverse. Authors should therefore make their manuscripts as accessible as possible, by keeping the needs of this broad-ranging audience in mind. Leukemia has at heart a desire not to expose authors to protracted reviewing periods that sometimes, unfortunately, result in rejection. To this end, we endeavour to provide you with a very rapid answer in the case of rejection; that is, 8 to 20 days after submission. Naturally, this may mean a manuscript is returned to authors without refereeing. This decision, however, is always made on the basis of a thorough scrutiny of each manuscript by the Editor.We wish to emphasise special features provided by Leukemia : Debates Round Table (see below) Spotlight On...a series of reviews, original manuscripts and Correspondence on a specific theme (see below). Debates Round Table and Spotlight On... both feature papers published over several issues. A co-ordinator is usually commissioned by the Editor-in-Chief. However, please write to the Editor-in-Chief if you are interested in co-ordinating either feature on a particularly stimulating topic. Meetings Calendar, Grants, News: Please send items for inclusion to the Editor-in-Chief. Acceptance is based on: NOVELTY, be it experimental, conceptual, or methodological. SCIENTIFIC RIGOR as for regular manuscripts. A manuscript will be considered for publication on the understanding that all named authors have agreed to its submission and that if accepted it will not subsequently be published in the same or similar form in any language without the consent of the publishers. A covering letter should accompany all submissions confirming the above points. The editors also encourage submission of review articles on relevant topics and recent developments. FORMAT OF PAPERSArticle Types Table
Preparation of Original Articles Abstract and Keywords The abstract should not exceed 200 words and three to six keywords should be included to aid web searches after publication. References Journal article, up to six authors: Oudejans JJ, Jiwa NM, Kummer, JA, Ossenkoppele GJ, van Heerde P, Baars JW et al. Activated cytotoxic T cells as prognostic marker in Hodgkin’s disease. Blood 1997; 89: 1376–1382. Journal article, e-pub ahead of print: Takeshita M, Ichikawa M, Nitta E, Goyama S, Asai T, Ogawa S et al. AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1. Leukemia 2008; e-pub ahead of print 13 March 2008; doi:10.1038/leu.2008.53. Journal article, in press: Whelan JT, Ludwig DL, Bertrand FE. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia. Leukemia (in press). EndNote users should select the Leukemia output style for the correct reference style. Book references should include up to six authors' names and initials plus et al as necessary, chapter title, name and initials of editor(s), book title, volume, edition, name and location of publisher, year of publication, first and last pages. Abstracts should be cited in the text and listed in the Reference List in the same format as other cited papers: Up to 6 authors (and et al when necessary). Abstract title. Name of journal year: volume; (abstract [number]). Personal communications should mention authors' names, month and year (a written authorization of the person cited should accompany the manuscript). Unpublished observations are not to be referenced but inserted in parentheses in the text (Descriptions of the data are required and should accompany the manuscript in triplicate, labelled 'for referees only'). Notes SUBMISSION OF PAPERSFirst, if you have not done so already, register for an account. HOME http://mts-leu.nature.com/letters/leu_copyright.pdfColour charges
Page charges The cost for each printed page of published manuscripts is £59 ($118) per page for first 6 pages, then £118 ($235) for each additional page. Further information To find out who to contact for advertising, subscriptions, permissions, papers in production or publishing a supplement, please visit our publisher’s contacts page. Alternatively, you can write to: Leukemia, Nature Publishing Group, The Macmillan Building, 4 Crinan Street, London, N1 9XW, UK.EDITORIAL POLICYCorrection and retraction process Non-Native Speakers of English Researchers who are not native speakers of English who submit manuscripts to international journals sometimes receive negative comments from referees or editors about the English-language usage in their manuscripts, and these problems can contribute to a decision to reject a paper. To help reduce the possibility of such problems, we strongly encourage such authors to take at least one of the following steps:
Please note that the use of Nature Publishing Group Language Editing is at the author's own expense and in no way implies that the article will be selected for peer review or accepted by an NPG journal (or any other journal). The decisions that the editors of any NPG journal make based on the quality and suitability of a manuscript for that journal are entirely independent of whether that manuscript has been language-edited by Nature Publishing Group Language Editing. Please press HOME to continue. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
| tracking system home | author instructions | reviewer instructions | help | tips | logout | journal home | terms of use |